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Abstract
Syphilis data from low- and middle-income countries are lacking due to limited testing. Point-of-care tests (POCTs) have
been promoted to expand testing but previously only included treponemal tests, which cannot distinguish active from past
infection. We aimed to assess the feasibility of using a combined treponemal and non-treponemal POCT in HIV clinic
patients in Gaborone, Botswana, and estimate syphilis prevalence in our clinic sample using this approach. We recruited
390 non-pregnant patients. Participants underwent a combined treponemal and non-treponemal POCT (Dual Path
Platform (DPP®) Syphilis Screen and Confirm Assay (Chembio Diagnostic Systems)) on finger-prick blood sample and
a questionnaire. Median age 45 years, 30%men, median CD4 count 565 cells/μL, and 91% had an HIV viral load <400 copies/
mL. Five participants had active syphilis (1.3%, 95% CI 0.5–3.0%) and 64 had previous syphilis (16.4%, 95% CI 13.0–20.4%)
using the DPP POCT. There was a reasonable level of agreement between digital and visual reading of the POCT (kappa
statistic of 0.81); however, visual reading missed three active infections (60%). The level of active syphilis was similar to local
antenatal data. The DPP POCT led to five participants with active syphilis being diagnosed and starting same-day treatment.
The digital reader should be used.
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Introduction
An estimated six million new cases of syphilis occur
worldwide each year, with the highest incidence and
prevalence in Africa.1,2 In low- and middle-income
countries (LMICs), syphilis prevalence estimates are
predominantly based on routine antenatal care (ANC) data,
which are extrapolated to the general population.3 Ante-
natal care screening is prioritized to avert cases of mother-
to-child transmission of syphilis which is associated with
stillbirth and other poor outcomes.4,5 Syphilis also in-
creases the risk of HIV transmission and acquisition, and
syphilis infection may lead to more severe disease man-
ifestations, including neurosyphilis, in those living with
HIV.6 The effective diagnosis and treatment of syphilis
among high-risk groups, including people living with HIV
(PLHIV), is important.
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Most syphilis prevalence data from Botswana are from
ANC, last reported in 2009, to be 1.3% nationally and 0.8%
in Gaborone, the capital city.7 An analysis of antenatal HIV
and rapid plasma reagin (RPR) test results from different
clinics in Botswana, across various periods between 2008
and 2016, found HIV-positive women to have a syphilis
infection rate of 1.5% and that HIV-positive women were
more likely to be infected with syphilis than HIV-negative
women.8 A 2012 study of at-risk groups in three urban areas
in Botswana found syphilis prevalence to be 3.5% among
female commercial sex workers (CSWs) and 2.7% among
men who have sex with men (MSM).9,10 The current adult
HIV prevalence in Botswana is 20.3%.11 A study assessing
syphilis prevalence among PLHIV conducted at the
country’s largest specialist HIV clinic in 2002, the same
setting as the current study, tested 143 patients at anti-
retroviral treatment (ART) initiation and found 9.8% with
a positive non-treponemal RPR test and a positive trepo-
nemal hemagglutination (TPHA) test.12 That study was
conducted prior to the implementation of the Botswana
national ART programme in 2002; as of 2018, ART cov-
erage of eligible PLHIV was 74–83% in Botswana.11,13
Where diagnostic access is limited, as is the case in
Botswana, a syndromic approach to genital ulcer disease
(GUD) is usually adopted. Patients with GUD are treated
with Benzathine Penicillin G and ceftriaxone to cover for
both syphilis and chancroid.14 Syndromic management has
limitations including the potential for unnecessary antimi-
crobial prescribing, only detecting symptomatic patients,
and not reaching a definitive diagnosis.14,15 The World
Health Organization (WHO) has advocated that countries
begin to move away from syndromic management as part of
the global strategy for sexually transmitted infection (STI)
control.16 A recent trial in Rwanda demonstrated that in-
troducing point-of-care tests (POCTs), including for syphilis,
allowed more accurate and targeted treatment of STIs.17
This strategy has the potential to greatly improve the
delivery of care for patients with STIs in LMICs. The WHO
has advocated the use of syphilis POCTs to expand the
availability of testing and reduce loss to follow-up and has
added such tests to its list of prequalified diagnostics.16,18
Earlier syphilis POCTs detected only treponemal anti-
bodies and therefore could not distinguish between active
syphilis infection (i.e. a positive treponemal and non-
treponemal test) and past exposure to treponemal infection
(i.e. a positive treponemal test only). More recent tests
such as the Dual Path Platform (DPP®) Syphilis Screen
and Confirm Assay (Chembio Diagnostic Systems, New
York) (DPP POCT) are different in that they incorporate
both a treponemal and non-treponemal test (reactive at
RPR ≥ 1:2) that can be used on whole blood, plasma or
serum.19 These tests, which currently cost approximately
US$2.50 per test, can be read manually by a healthcare
worker or analyzed using a digital reader.20 A 2016 meta-
analysis of published and unpublished data using the DPP
syphilis POCT collated nine evaluations representing more
than 7200 individual samples.21 Overall agreement between
the DPP POCT and reference serology (RPR, Venereal
Disease Research Laboratory, treponema pallidum particle
agglutination or TPHA) was 85.2%. High titre samples
(RPR ≥ 1:16) had a 98% sensitivity and 100% specificity for
the treponemal test and 98% sensitivity for the non-treponemal
test. Low titre samples (RPR < 1:16) had a 93% sensitivity
and 98.5% specificity for the treponemal test and 85%
sensitivity and 87.6% specificity for the non–treponemal
test.21 A 2017 field evaluation of the DPP POCT visual
reading compared to laboratory tests found misclassification
of the non-treponemal test with RPR titres <1:8.22 Tests
conducted by the manufacturer of DPP indicate there is
a correlation between RPR titre and density of the non-
treponemal test line and that digital readers were better at
reading low RPR titres than a visual read.19 The use of a
digital reader for DPP may therefore increase its sensitivity.
We performed a study to assess the feasibility of using
a combined treponemal and non-treponemal POCT in pa-
tients attending an HIV clinic in Botswana and compared
the outcomes of visual versus digital readings of the POCT
result. We also estimated the prevalence of syphilis infection
using this approach in non-pregnant adults attending our
clinic.
Methods
Study design, setting and sample
We conducted a cross-sectional study in the Infectious
Disease Care Clinic (IDCC) at Princess Marina Hospital
(PMH), the largest public referral hospital in Botswana. The
IDCC is an outpatient clinic which provides care for PLHIV
from Gaborone and outlying areas. We approached all
consecutive clinic attendees aged 18 years or over pre-
senting for routine appointments, every day of clinic op-
eration, over a four-week period. Patients were ineligible if
they were unable to consent, currently receiving treatment
for syphilis (so as not to unduly burden the patient), or
pregnant (all pregnant women are routinely tested at their
ANC booking visit and treated as per Botswana national
guidelines). Using syphilis prevalence data from CSWs,
MSM and pregnant women in Botswana, the prevalence
among HIV patients in Botswana was estimated at 2%. We
calculated that a sample size of 335 was needed to measure
a prevalence of 2 ± 1.5%.
Study procedures
All IDCC clinic patients were briefly informed about the
study in Setswana, the local language, and English, as they
registered for their HIV appointment; more detailed an-
nouncements were made outside clinic rooms whilst pa-
tients waited to see a doctor. Those who were interested in
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participating were provided with additional information by
study staff. After screening and written consent, eligible
participants were enrolled.
Data were collected on socio-demographic character-
istics, medical history, sexual health behaviours and history
of syphilis and GUD. Interviews were conducted in the
participant’s language of preference by a research assistant.
HIV viral load (VL), CD4 cell count, ART status and
previous RPR tests (the standard syphilis screening test used
at HIV diagnosis and whenever clinically indicated) were
extracted from medical notes. The DPP POCT was con-
ducted by research nurses, who were trained in the test
procedures. All tests were conducted by the two nurses, in
rotation, throughout the study period.
The POCT (Figure 1) has three lines, a treponemal,
a non-treponemal and a control line (which indicates
whether the test is functioning). The test requires 10 μL of
blood, and pipettes are included in the kit. The blood is
added to the first well along with two drops of a buffer
solution. After five minutes, five drops of buffer solution are
added to the second well, and the test is read after a further
15 min. A visible line indicates a reactive test at the trep-
onemal, non-treponemal and control lines. If no control line
was visible, the test was considered unusable and was
repeated.
All POCT results were first read visually and recorded by
the nurse, and then separately read by the study doctor,
blinded to visual result, using a battery-powered digital
reader, which gives a positive or negative result for each test
line. The reader was handheld, similar in size to the POCT,
clipped onto the test cassette and operated by pressing
a single button. The digital read was considered the de-
finitive result on which treatment decisions were based, in
line with the manufacturer’s instructions.19
Point-of-care tests results were given to all participants at
the same clinic visited by the research team and recorded in
the participant’s medical notes. All participants with active
syphilis (reactive treponemal and non-treponemal tests)
underwent a clinical assessment to identify neurological
symptoms that might warrant further investigation and were
prescribed doxycycline (100 mg twice a day for 28 days), in
line with the Botswana national STI treatment guidelines
and current drug availability, due to stock outs of Benzathine
Penicillin G. They were also counselled about partner
notification and given contact slips, the standard for STI
partner notification in Botswana. Participants with a posi-
tive treponemal test were counselled on past syphilis in-
fection. All participants were asked a single open-ended
question about whether they would want to take part in
future STI screening and treatment in the context of their
HIV care.
Statistical analysis
The primary outcome was active syphilis infection, defined
as a positive treponemal and non-treponemal antibody re-
sult. Secondary outcomes were proportion of participants
testing positive for treponemal antibody alone (past syphilis
infection) and non-treponemal antibody alone (non-specific
reactive result). We compared the results of visual versus
digital read of the POCT. Descriptive data were generated
for active syphilis infection and participant characteristics.
Bivariate associations of participant characteristics with
active syphilis and past syphilis infection were evaluated
using chi-squared and Fisher’s exact tests and unadjusted
odds ratios. Agreement between visual and digital POCT
readings was calculated using an unweighted kappa sta-
tistic. The sensitivity and specificity of visual readings
compared to the definitive digital reading results were
calculated for active syphilis (versus other) and past syphilis
infection (versus other). Paper questionnaires were double-
entered into EpiData v4.2 and analyzed using Stata 14.
Ethical approval
The protocol was approved by the Botswana Health Re-
search Development Committee at the Ministry of Health
and Wellness, the University of Botswana Office of Re-
search and Development Research Ethics Committee, the
Research and Ethics Committee of PMH and the London
School of Hygiene and Tropical Medicine MSc Research




During the four-week study period from July to August
2017, 801 adult patients attended the HIV clinic of whom
301 were men (38%) and 500 women (62%). A total of 400
Figure 1. Dual Path Platform Syphilis Screen and Confirm
Assay (Chembio Diagnostic Systems, New York); complete
cassette.
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attendees (50%) expressed interest in study participation
and were screened for eligibility; 391 (98%) were enrolled,
and 390 included in analysis (Figure 2).
Seventy percent (n = 272) were women and 30% (n =
118) were men (Table 1). Median age was 45 years (in-
terquartile range (IQR) 40–51 years), and median CD4 cell
count was 565 cells/μL (IQR 392–729 cells/μL). Three
hundred and eighty-seven participants (99%) were on ART
and 344 (91%) had a VL < 400 copies/mL. Seventy-three
participants (19%) reported having had a syphilis test in the
past, with 11 of those (15%) reporting a previous positive
syphilis test result (five men and six women). No partic-
ipants reported current genital ulcers. Ninety-nine partic-
ipants (25.5%) reported having had genital ulcers in the
past, of whom 23 reported them as painless (6% of all
participants).
Point-of-care tests outcomes
All finger-prick blood samples produced usable POCT
results as indicated by a positive control line. The median
time from sample collection to reading of the result was
20 min (range 18–30 min). Results of the DPP POCTs are
presented in Table 2. Using the definitive digital reading
results, five of the 390 participants had both positive
treponemal and non-treponemal test results (1.3%, 95% CI
0.5–3.0%), indicating active syphilis infection; all five
initiated syphilis treatment at the same clinic visit. Sixty-
four of the 390 participants tested positive for treponemal
antibody alone (16.4%, 95% CI 13.0–20.4%) indicating
evidence of a past syphilis infection. Ten participants tested
positive for the non-treponemal test alone (2.6%; 95% CI
1.4–4.7%), indicating a non-specific reactive result. The
total number of participants with syphilis exposure (com-
bining active and past syphilis infection) was 69 (17.7%;
95% CI 14.2–21.8%).
Of the 23 participants who reported ever having painless
genital ulcers in the past, 35% (n = 8) tested positive for the
treponemal antibody. The majority of the 69 participants
who tested positive for treponemal antibody (n = 54, 78%)
did not report any history of genital ulceration, painless
or painful. Of the 11 participants who reported having had
a positive syphilis test result in the past, nine had negative
test results, one tested positive for treponemal antibody
alone and one tested positive for the non-treponemal test
alone.
In bivariate analysis, no characteristics were associated
with active syphilis infection (data not shown). The only
characteristics associated with active or past syphilis in-
fection were increasing age (p < 0.001) and lower levels of
education (p = 0.001). There was no association between
reporting a history of genital ulceration (any, painless or
painful) with syphilis infection or treponemal exposure.
Five (1.4%) of the participants identified as MSM; all of
whom had negative test results.
Performance of visual versus digital readings
Overall agreement between visual and digital readings was
93.85%, giving a kappa statistic of 0.812 (Table 3). Using
the digital reading as the definitive result, visual reading
misclassified three of the five (60%) active syphilis in-
fections as past syphilis infections. For active syphilis (both
positive treponemal and non-treponemal tests), the sensi-
tivity of the visual reading compared to the definitive digital
reading was 40% (95% CI 5.27–85.3%) and the specificity
was 99.5% (95% CI 98.1–99.9%). For treponemal antibody
alone (indicating prior syphilis infection), the sensitivity of
visual reading compared to definitive digital reading was
89.1% (95% CI 78.8–95.5%) and the specificity was 96.9%
(95% CI 94.4–98.5%).
Almost all participants (96%, n = 365) reported that they
would like to participate in STI testing programmes in the
context of their HIV care in the future.
Discussion
In this cross-sectional study of self-selected non-pregnant
patients attending an HIV clinic in Gaborone, Botswana, the
prevalence of active syphilis infection was 1.3% using the
DPP POCT. This is the second study to investigate syphilis
prevalence among HIV-infected individuals in Botswana,
and the first in the era of ART, using a POCT to test and treat
on the same day. All DPP POCTs gave usable results, shown
by a visible control line, and led to the five participants with
a positive result for active syphilis infection being di-
agnosed and starting treatment on the same day.
Figure 2. Flow of participants in a study of syphilis testing,
using Dual Path Platform Point-of-care tests during their HIV
care clinic visit in Botswana.
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Table 1. Socio-demographic and health history characteristics of non-pregnant HIV clinic attendees in Botswana participating in
a syphilis testing study using DPP POCT during an HIV care clinic visit.
Characteristic N = 390 n (%)
Gender (n = 390)
Male 118 (30%)
Female 272 (70%)
Age (n = 390); median age in years (IQR) 45 (40–51)
20–29 years 8 (2%)
30–39 years 72 (18%)
40–49 years 187 (48%)
50 years or older 123 (31%)
Relationship status (n = 389)
Married 109 (28%)
Current relationship, not married 178 (46%)
Single, no current relationship 102 (26%)




Higher than secondary/vocational 60 (16%)





Viral load, copies/mL <400 (n = 376) 344 (91%)
Number of sexual partners in past 12 months (n = 389)
None 76 (19.5%)
One 282 (72.5%)
Two or more 31 (8%)
Condom used at last sexual intercourse (n = 380) 266 (70%)
Men who have sex with men (n = 357) 5 (1.4%)
Reports having had a previous syphilis test (n = 386) 73 (19%)
Previous syphilis test result positive (n = 73) 11 (15%)
Reports history of genital ulcers (n = 388) 99 (25.5%)
Reports history of painless genital ulcers (n = 388) 23 (6%)
DPP®: Dual Path Platform; POCT: Point-of-care test; IQR: interquartile range.
Table 2. Results of syphilis testing using the DPP POCT (with digital reading) among non-pregnant HIV clinic attendees participating





clinic sample, % 95% confidence interval
Active syphilis infection (treponemal and non-treponemal) 5 1.3 0.5–3.0%
Past syphilis infection (treponemal only) 64 16.4 13.0–20.4%
Non-specific reactive result (non-treponemal only) 10 2.6 1.4–4.7%
Negative (non-reactive) 311 79.7 75.4–83.5%
Total syphilis exposure (active plus past) 69 17.7 14.2–21.8%
DPP®: Dual Path Platform; POCT: Point-of-care test.
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The proportion of participants in this study sample with
active syphilis infection is comparable to the 1.6% preva-
lence across the WHO African region and 0.8% prevalence
among Gaborone ANC attendees,3,7 but substantially lower
than was found in a study conducted in 2002 in the same
HIV clinic, which estimated a syphilis prevalence of
9.8%.12 The lower proportion of syphilis infection found in
our study compared to the earlier study in the HIV clinic
population may reflect a reduction in syphilis in the overall
population, a general trend that has also been observed in
Botswana’s ANC data between 2004 and 2008 and which is
attributed to syndromic STI management.23 However, it is
also likely to represent differences in the study populations
which were independently selected from the clinic. In the
earlier study, all participants were ART-naı̈ve, with a median
CD4 cell count of 104 cell/μL and had a lower median age
than our population of older, ART-experienced individuals,
and no exclusion criteria were noted. The estimated level
of active syphilis in this group of ART-experienced, non-
pregnant HIV clinic attendees was lower than in other at-
risk groups such as MSM and CSWs in Botswana.9,10,16
Very few MSMs were included in our sample, and no data
on CSWs were collected, precluding any robust estimates in
these groups.
Although no participant characteristics were associated
with active syphilis infection in this small study, we
identified some factors associated with past infection. In-
creasing age was associated with syphilis exposure with the
proportion increasing from 6% in those aged 20–30 years to
28% in those over 50 years. This is similar to the findings of
a population-based survey in Rwanda24 and a study con-
ducted in Ethiopia25 and likely reflects the longer duration
of exposure risk with advancing age and measurement of
an antibody which persists for life. Lower education levels
were associated with higher rates of syphilis exposure,
which has also been reported in prior African studies25 but
may also reflect an association between increasing age and
lower educational attainment. Most people reporting a his-
tory of genital ulceration in our study did not test positive
for treponemal antibody suggesting a different pathology of
GUD in the majority of cases in our setting. Although
painless genital ulceration was associated with the presence
of treponemal antibody, the majority of those with trepo-
nemal antibody reported no history of genital ulceration.
This highlights the importance of moving towards diagnostic-
driven diagnosis for STIs using rapid diagnostics such as
the DPP POCTs in resource-constrained environments.
There was a high level of agreement between digital and
visual reading of the DPP POCT in this study, and the kappa
statistic of 0.81 indicates good agreement beyond chance.
However, visual reading missed three of the five active
infections (60%). Our data therefore suggest that the digital
reader should be used when performing the DPP POCT to
avoid missing active infections. No previous published data
have compared visual and digital readings for the DPP
POCT; one previous laboratory-based study looking at the
DPP POCT found a 1.5% disagreement between two visual
operators.26 If digital readers are not available, a visual
reading by two individuals trained in use of the POCTs
should be undertaken as this has been shown in field tests to
have 99.5% agreement.22
Using the dual antibody DPP test, compared to the re-
sults that would have been provided by RPR screening
alone, prevented 10 patients with non-specific reactive
results in this study from unnecessarily being treated
for syphilis. Importantly, compared to a treponemal-only
POCT, the 64 treponemal antibody-only participants were
not treated or required to undergo further blood tests. In
practice, using the dual antibody test and correlating with
any previous treatment history could reduce the number of
cases misdiagnosed as active syphilis, obviating the need for
treatment and contact tracing. This would avoid causing
unnecessary distress for patients and conserve time and
resources for healthcare services which are particularly
important, given periods of global Benzathine Penicillin
G shortage.27,28 The current price of the DPP POCT at
US$2.50 is significantly more expensive than the average
cost per vial of Benzathine Penicillin G in LMICs at
US$0.20.28 However, this comparison does not take into
account the clinic and staff costs associated with its ad-
ministration or the implications of exacerbating present
drug shortages. Detailed costing studies are required to
further evaluate the utility of this approach.
Our study has several limitations including the relatively
small sample size, clinic-based recruitment, the self-
selection of participants into the study and the exclusion
of pregnant women and patients currently being treated for
syphilis, limiting the representativeness of our sample of
the HIV-positive population of Botswana and our ability to
generalize the prevalence of active syphilis to the population
of PLHIV in Botswana. In addition, 62% of clinic attendees
but 70% of the included population were women. Partic-
ipants were actively engaged with health services and on
ART with high CD4 cell counts and suppressed HIV VLs,
which could potentially exclude those most at risk of active
syphilis. However, the study population is representative of
approximately 70% of the PLHIV in Botswana.13 Medical
notes were often incomplete with respect to previous
syphilis test data so that information was self-reported. A
comparator laboratory test was not performed to confirm the
results. The DPP POCT is less sensitive in those with an
RPR titre <1:16, and patients with advanced immunosup-
pression often do not develop high RPR titre response to
syphilis infection; and individuals with late latent syphilis
may have been missed. Data from the manufacturer indicate
a correlation between the density of the non-treponemal line
displayed on the digital readers and RPR titres; however,
these data were not captured in this study.19 It was therefore
not always possible to determine if patients with a positive
treponemal antibody alone had either previously treated
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syphilis or late latent syphilis. A cost-benefit analysis was
not included in this study. A previous study found the dual
antibody POCT, at its current price, was less cost-effective
in two Sub-Saharan African sites compared to treponemal
antibody tests and would need to be reduced in price by
a half to be cost-effective in those settings.20 Only half
of clinic attendees over the study period participated and
reasons for declining participation were not collected.
In conclusion, the results of our study show the level of
active syphilis in this clinic-based sample of PLHIV to be
similar to national ANC prevalence and lower than in other
at-risk groups in Botswana. Testing with the DPP POCT,
using a digital reader, was able to give same-day results to
participants during a clinic visit, differentiate between active
and past infection, identify five active infections requiring
treatment and reduce unnecessary antimicrobial use. The
digital reader should be used when using the DPP POCT to
avoid missing infections.
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